Qualifying conditions for medical cannabis include the following:
- Post-TraumaticStress Disorder (PTSD)
- Cancer
- ALS
- Autism Spectrum
- Dementia
- Seizures
- Spasticity
- Incurable Degenerative Disease
More Conditions That Qualify
A
- Adenylosuccinate synthase Deficiency
- Alexander
- ALS (Amyotrophic Lateral Sclerosis)
- Alzheimer's Disease and other dementias
- Amyloidoses
- Argyrophilic Grain Disease
- Aromatic L-amino acid decarboxylase deficiency
- Asparylglucosaminuria
- Ataxia neuropathy spectrum
- Autism and other spectrum disorders
- Bidirectional enzyme deficiency
- Biopterin Defects
B
C
- Canavan disease
- Cancer
- Central Core
- Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
- Cerebral Palsy
- Charcot Marie Tooth and related hereditary neuropathies
- Childhood Myocerebrohepatopathy spectrum
- Congenital Disorders of Glycosylation
- Corticobasal Degeneration
- Creatine Disorders
- Creatine Transporter Defect, also known as SLC 6A8
- Creutzfeldt-Jakob Disease
- CTE (Chronic Traumatic Encephalopathy)
- Dementia with Lewy Bodies
- Deoxyguanisine kinase deficiency
- Dihydropirimidinase Deficiency
- Dihydropteridine reductase
- Dihydropyrimidine dehydrogenase Deficiency
- Duchenne Muscular Dystrophy
D
- Facioscapulohumeral Muscular Dystrophy
- Familial or Sporadic Fatal Insomnia
- Familial Spastic Paraplegia
- Farber Disease
- Fatty Acid Oxidation
- Freidreich’s Ataxia
- Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
- Frontotemporal Lobar Degeneration
F
G
- Galactosemia
- Galactosialidosis
- Gaucher Type 2 and Type 3
- Gerstmann-Straussler-Scheinker Disease
- Globular Glial Tauopathy
- Glutaric acidemia type 1
- Glycine encephalopathy, also known as non-ketotic hyperglycinemia
- Glycogen Storage-Lysosomal: Pompe Disease
- GM1 gangliosidosis
- GM2 gangliosidosis also known as Tay-sachs and Sandhoff Disease
- Guanidinoacetate methytransferase deficiency
- Guanosine triphosphate cyclohydrolase deficiency
- Homocysteine re-methylation defects
- Huntington's Disease
- Hypoxanthine-guanine phosophoribosyltransferase Deficiency also known as Lesch-Nyhan disease
H
K
- Kearn Sayers Syndrome
- Krabbe
- Kuru
- L-2-hydroxyglutaric aciduria
- L-Arginine/glycine amidinotransferase deficiency
- Leukodystrophy
- Lewy Body Disorders
- Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
- Lysosomal Storage Diseases
L
M
- Mannosidosis
- Manosidosis alpha and beta
- Maple Syrup Urine Disease
- Metachromatic leukodystrophy
- Metal Metabolism
- Mitochondrial Conditions
- Mitochondrial Depletion syndromes types 1 through 14
- Mitochondrial Encephalopathy Lactic Acidosis Stroke
- Mitochondrial Encephalopathy Ragged Red Fiber
- Mitochondrial neurogastrointestinal encephalopathy
- Monoamine oxidase deficiency
- Motor Neuron Disease
- MS (Multiple Sclerosis)
- Mucolipidoses
- Mucolipidoses Type II, also known as Inclusion Cell disease
- Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
- Mucopolysaccaridosis
- Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
- Mucopolysaccharidosis Type II, also known as Hunter Syndrome
- Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
- Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
- Mucopolysaccharidosis Type VII, also known as Sly
- Multiple Sulfatase deficiency
- Multiple System Atrophy
- Muscular Dystrophies
- Myoclonic epilepsy myopathy sensory ataxia
- Neimann Pick Type A and B
- Neimann Pick Type C
- Neonatal Adrenoleukodystrophy
- Neurodegeneration with brain iron accumulation
- Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
- Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
- Neuropathy, Ataxia, and Retinitis Pigmentosa
- Neurotransmitter defects
N
- Pantothenate Kinase Associated Neurodegeneration
- Parkinson's Disease
- Pelizaeus-Merzbacher disease
- Peripheral Neuropathies
- Peripheral neuropathy types 1 through 4
- Peroxisomal biosynthesis defects
- Peroxisomal Disorders
- Pick Disease
- Polymerase G Related Disorders
- Polyol disorders
- Primary Lateral Sclerosis
- Prion Diseases
- Progressive Choreas
- Progressive dystonias DYT genes 1 through 20
- Progressive Muscular Atrophy
- Progressive Supranuclear Palsy
- Pterin-4-carbinolamine dehydratase
- PTSD
- Purine and Pyrimidine Defects
- Pyruvate Carboxylase Deficiency
- Pyruvate Dehydrogenase Deficiency
- Pyruvoyl-tetahydropterin synthase
P
R
- Refsum Disease
- Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects
- RRM2B-related mitochondrial disease
- Salidosis
- Schindler
- Segawa Diease, also known as Dopamine Responsive Dystonia
- Sepiapterin reductase
- Sialidosis
- Spasticity
- Schindler
- Sphingolipidoses
- Spinal Muscular Atrophy
- Spinal-bulbar muscular atrophy
- Spinocerebellar ataxia
- Subacute necrotizing encephalopathy, also known as Leigh syndrome
- SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
- Synucleinopathies
S
T
- Tauopathies
- Thymidine Kinase
- Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies
- Trifunctional protein deficiency
- X-linked adrenoleukodystrophy
X
